Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9453105 | 0.78 | KDM4C (0.32) | ALDH1A1SMN1; SMN2MAPTPIM1KDM4C | |
| SCHEMBL19482662 | 0.77 | HPGD (0.37) | ALDH1A1SMN1; SMN2HCAR2KDM4E | |
| SCHEMBL3579095 | 0.75 | GRM5 (0.38) | ALDH1A1SMN1; SMN2MAPTHCAR2KDM4E | |
| SCHEMBL9319179 | 0.74 | PGK1 (0.58) | ALDH1A1KDM4E | |
| SCHEMBL3577400 | 0.74 | GRM5 (0.56) | ALDH1A1SMN1; SMN2PIM1HCAR3YTHDC1 | |
| SCHEMBL13346059 | 0.74 | GRM5 (0.37) | ALDH1A1SMN1; SMN2MAPTHCAR2PIM1 | |
| SCHEMBL14399014 | 0.72 | KDM4E (0.36) | ALDH1A1KDM4ETDP1 | |
| SCHEMBL3580632 | 0.72 | KDM4E (0.43) | ALDH1A1MAPTHCAR2NPSR1KDM4E | |
| SCHEMBL30206064 | 0.72 | KDM4E (0.43) | ALDH1A1MAPTHCAR2NPSR1KDM4E | |
| SCHEMBL30588867 | 0.71 | KEAP1 (0.32) | ALDH1A1KDM4EYTHDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708336-B2 | Anodic oxidation of 5-aminouracil | MEDIBEACON INC. (US) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708336-B2 | Anodic oxidation of 5-aminouracil | DPYD, DHODH, AASDHPPT | ALDH1A1 297/4885SMN1; SMN2 2424/4885MAPT 4050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.